Government of CanadaPublic Health Agency of Canada / Agence de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

 

Volume: 22S1 • April 1996

Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings

REFERENCES

  1. CDC. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons — Florida and New York, 1988-1991. MMWR 1991;40:585-91.
  2. Coronado VG, Beck-Sagué CM, Hutton MD et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993;168:1052-55.
  3. Pearson ML, Jereb JA, Frieden TR et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992;117:191-96.
  4. Beck-Sagué C, Dooley SW, Hutton MD et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280-86.
  5. Edlin BR, Tokars JI, Grieco MH et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514-21.
  6. Jarvis WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Res Microbiol 1993;144;2:117-22.
  7. Fridkin SK, Manangan L, Bolyard E et al. SHEA-CDC TB Survey, Part I: Status of TB Infection Control Programs at Member Hospitals, 1989-1992 and Part II: Efficacy of TB Infection Control Programs at Member Hospitals, 1992. Infect Control Hosp Epidemiol 1995;16;3:129-40.
  8. Statistics Canada. Tuberculosis statistics 1993. Ottawa: Statistics Canada, 1995 (Cat. No. 82-220).
  9. Tuberculosis Committee, Canadian Thoracic Society. Essentials of tuberculosis control for the practising physician. Can Med Assoc J 1994;150:1561-71.
  10. Statistics Canada. Tuberculosis statistics 1990. Ottawa: Statistics Canada, 1992 (Cat. No. 82-003S10).
  11. Statistics Canada. Tuberculosis statistics 1991. Ottawa: Statistics Canada, 1993 (Cat. No. 82-220).
  12. Statistics Canada. Tuberculosis statistics 1992. Ottawa: Statistics Canada, 1994 (Cat. No. 82-220).
  13. Gaudette LA, Ellis E. Tuberculosis in Canada: a focal disease requiring distinct control strategies for different risk groups. Tuber Lung Dis 1993;74:244-53.
  14. Orr P, Manfreda J, Hershfield E. Tuberculosis surveillance in immigrants to Manitoba. Can Med Assoc J 1990;142:453-58.
  15. Health and Welfare Canada. Guidelines for the investigation of individuals who were placed under surveillance for tuberculosis post-landing in Canada. CCDR 1992;18:153-60.
  16. Enarson DA, Wade JP, Embree V. Risk of tuberculosis in Canada: implications for priorities in programs directed at specific groups. Can J Public Health 1987;78:305-08.
  17. Enarson DA, Wang J, Dirks JM. The incidence of active tuberculosis in a large urban area. Am J Epidemiol 1989;129:1268-76.
  18. Korzeniewska-Kosela M, FitzGerald JM, Vedal S et al. Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases. Can Med Assoc J 1992;146:1927-34.
  19. Bloch AB, Cauthen GM, Onorato IM et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271:665-71.
  20. Eidus L, Jessamine AG, Hershfield ES et al. A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment cases. Can J Public Health 1978;69:146-53.
  21. Long R, Fitzgerald M, Fanning A, Cowie R, Hoeppner V and the Western Canada Tuberculosis Group. Antituberculous drug resistance in Western Canada (1993-94). Am J Respir Crit Care Med 1995;151:A513 (Abstract).
  22. Selwyn PA, Hartel D, Lewis VA et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
  23. Barnes PF, Bloch AB, Davidson PT et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-50.
  24. Troy CJ. Epidemiology of tuberculosis in Ontario 1989-1992. Public Health and Epidemiology Report Ontario (PHERO) 1994;5:63-72.
  25. Fanning A, Devine R, Flowerdew G. Human HIV seroprevalence in newly-diagnosed cases of tuberculosis (TB) in Alberta, Canada. Am Rev Resp Disease 1993;147:Suppl A488.
  26. Canadian Thoracic Society, Tuberculosis Directors of Canada, and Health and Welfare Canada. Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and human immunodeficiency virus infection. CCDR 1992;18:155-60.
  27. Holton D, Gibson H, Whyman C et al. TB hospital readiness study, 1989-1993. Presented at the 1995 CHICA Conference, May 1-3, 1995, Winnipeg, Manitoba.
  28. Menzies D, Fanning A, Yuan L et al. Tuberculosis among health care workers. N Engl J Med 1995;332:92-8.
  29. Bleiker MA. Epidemiological trends in low prevalence countries. Bull Int Union Tuberc Lung Dis 1974;49:128-35.
  30. Sepkowitz K. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med 1994;120:71-9.
  31. Grzybowski S, Allen EA, Black WA et al. Inner-city survey for tuberculosis: evaluation of diagnostic methods. Am Rev Respir Dis 1987;135:1311-15.
  32. Stead WW. Tuberculosis among elderly persons: an outbreak in a nursing home. Ann Intern Med 1981;94:606-10.
  33. Small PM, Shafer RW, Hopewell PC et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137-44.
  34. Beresford OD. Tuberculin skin sensitivity in old age. Am Rev Resp Dis 1958;77:323-28.
  35. Barnett GD, Grzybowski S, Styblo K. Present risk of developing active tuberculosis in Saskatchewan according to previous tuberculin and x-ray status. Bull Int Union Tuberc Lung Dis 1971;45:51-74.
  36. CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43(No. RR-13):1-132.
  37. Colditz GA, Brewer TF, Berkley CS et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698-702.
  38. Health and Welfare Canada. Infection control guidelines: organization of infection control programs in health care facilities. Ottawa, Health and Welfare Canada, 1990. (Supply and Services Canada, Cat. No. H30-11-6-5E.)
  39. Styblo K, Salomäo MA. National tuberculosis control programs. In: Reichman LB, Hershfield ES, editors. Tuberculosis: A comprehensive international approach. New York: Marcel Dekker, 1993:573-600.
  40. Last J. A dictionary of epidemiology. 2nd ed. Toronto: Oxford University Press, 1988.
  41. CDC. Screening for tuberculosis and tuberculous infection in high-risk populations, and the use of preventive therapy for tuberculous infection in the United States: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR 1990;39(No. RR-8):1-12.
  42. American Thoracic Society and CDC. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142:725-35.
  43. Standards Committee (Tuberculosis), Canadian Thoracic Society. Canadian tuberculosis standards. 3rd ed. Ottawa: Canadian Lung Association, 1988.
  44. Barnes PF, Barrows SA. Tuberculosis in the 1990s. Ann Intern Med 1993;119:400-10.
  45. CDC. Guidelines for preventing the transmission of tuberculosis in health care settings, with special focus on HIV-related issues. MMWR 1990;39(No. RR-17):1-27.
  46. CDC. Mycobacterium tuberculosis transmission in a health clinic — Florida, 1988. MMWR 1989;38:256-64.
  47. Kantor HS, Poblete R, Pusateri SL. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 1988;84:833-38.
  48. Goldman KP. Tuberculosis in hospital doctors. Tubercle 1988;69:237-40.
  49. Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis 1982;125:559-62.
  50. Ehrenkranz NJ, Kicklighter JL. Tuberculosis outbreak in a general hospital: evidence for airborne spread of infection. Ann Intern Med 1972;77:377-82.
  51. Haley CE, McDonald RC, Rossi L et al. Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol 1989;10:204-10.
  52. Riley RL. Airborne infection. Am J Med 1974;57:466-75.
  53. Narain JP, Lofgren JP, Warren E et al. Epidemic tuberculosis in a nursing home: a retrospective cohort study. J Am Geriatr Soc 1985;33:258-63.
  54. Stead WW, Lofgren JP, Warren E et al. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985;312:1483-87.
  55. Health and Welfare Canada and the Medical Research Council of Canada. Laboratory biosafety guidelines. Ottawa: Supply and Services Canada, 1990 (Cat. No. MR 21-1/1990E).
  56. CDC. The use of preventive therapy for tuberculosis infection in the United States: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR 1990;39(No. RR-8):9-12.
  57. American Thoracic Society and CDC. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:159-74.
  58. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Short-course therapy for tuberculosis in infants and children. Can Med Assoc J 1994;150:1233-39.
  59. Canadian Standards Association. Special requirements for heating, ventilation, and air conditioning (HVAC) systems in health care facilities: a national standard of Canada. 1991.(CAN/CSA-Z317.2-M91.)
  60. Otten J, Chen J, Cleary T. Successful control of an outbreak of multidrug-resistant tuberculosis in an urban teaching hospital. World Congress of Tuberculosis. Program and abstracts. Bethesda, Md.: National Institutes of Health, 1992;51. Abstract.
  61. Sharp V, Lockhart B, Brassel J et al. Dramatic decrease of MDR-TB after implementing CDC/New York State TB control measures at a New York City outbreak hospital. In: Proceedings of the Ninth International Conference on AIDS/Fourth STD World Congress, Berlin, Germany, June 6-11, 1993. London: Wellcome Foundation, 1993:329. Abstract.
  62. Kent J, Pearson ML, Hewlett D et al. Control of nosocomial outbreak of multidrug-resistant tuberculosis (MDR-TB) among HIV-positive (HIV+) patients. In: Proceedings of the Ninth International Conference on AIDS/Fourth STD World Congress, Berlin, Germany, June 6-11, 1993. London: Wellcome Foundation, 1993:330. Abstract.
  63. Stroud LA, Tokars JI, Grieco MH et al. Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol 1995;16:141-47.
  64. Jarvis WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Am J Infect Control 1995;23:146-51.
  65. Grist NR, Emslie JAN. Infections in British clinical laboratories, 1988-1989. J Clin Pathol 1991;44:667-69.
  66. Nardell EA. Fans, filters or rays? Pros and cons of the current environmental tuberculosis control technologies. Infect Control Hosp Epidemiol 1993;14:681-85.
  67. Fraser VJ, Johnson K, Primack J et al. Evaluation of rooms with negative pressure ventilation used for respiratory isolation in seven midwestern hospitals. Infect Control Hosp Epidemiol 1993;14:623-28.
  68. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis 1992;146:1623-33.
  69. Riley RL, Nardell EA. Clearing the air: the theory and application of ultraviolet air disinfection. Am Rev Respir Dis 1989;139:1286-94.
  70. Calder RA, Duclos P, Wilder MH et al. Mycobacterium tuberculosis transmission in a health clinic. Bull Int Union Tuberc Lung Dis 1991;66:103-06.
  71. Hutton MD, Stead WW, Cauthen GM et al. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 1990;161:286-95.
  72. Dooley SW, Villarino ME, Lawrence M et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992;267:2632-34.
  73. Fischl MA, Uttamchandani RB, Daikos GL et al. An outbreak of tuberculosis caused by multiple-drug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992;117:177-83.
  74. Nardell EA, Keegan J, Cheney SA et al. Airborne infection: theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis 1991;144:302-06.
  75. Riley RL. Aerial dissemination of pulmonary tuberculosis. Am Rev Tuber Pulmon Dis 1957;76:931-41.
  76. Macher JM. The use of germicidal lamps to control tuberculosis in health care facilities. Infect Control Hosp Epidemiol 1993;14:723-29.
  77. ASHRAE handbook. Heating, ventilating and air conditioning systems and applications. Atlanta, GA: American Society of Heating, Refrigeration and Air Conditioning Engineers, 1995 (updated every four years).
  78. Health and Welfare Canada. Infection control guidelines: V. Guidelines for hospital environmental control. Ottawa: Health and Welfare Canada, 1988 (Supply and Services Canada, Cat. No. H30-11-6-4E.)
  79. National Institute for Occupational Safety and Health. NIOSH recommended guidelines for personal respiratory protection of workers in health-care facilities potentially exposed to tuberculosis. Atlanta: Department of Health and Human Services, 1992:1-55.
  80. Occupational Safety and Health Administration. CFR 1910.134: occupational safety and health standards, personal protective equipment, respiratory protection. In: Code of federal regulations. Washington, D.C.: Office of the Federal Register, 1994.
  81. Adal KA, Anglim AM, Palumbo CL et al. The use of high-efficiency particulate air-filter respirators to protect hospital workers from tuberculosis: a cost-effectiveness analysis. N Engl J Med 1994;331:169-73.
  82. Nettleman MD, Fredrickson M, Good NL et al. Tuberculosis control strategies: the cost of particulate respirators. Ann Intern Med 1994;121:37-40.
  83. Skinner C, Ormerod P, Campbell I et al. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 1994. Thorax 1994;49:1193-200.
  84. National Institute for Occupational Safety and Health (NIOSH). CFR 42 part 84, RIN0905-AB58. Protective devices: final rules and notice. In: Rules and Regulations. Vol 60, No 110, June 8, 1995. Atlanta: CDC.
  85. Riley RL. Airborne pulmonary tuberculosis. Bacteriol Rev 1961:25:243-48.
  86. Chen CC, Willeke K. Aerosol penetration through surgical masks. Am J Infect Control 1992;20:177-84.
  87. Nicas M. Respiratory protection and the risk of Mycobacterium tuberculosis infection. Am J Industr Med 1995;27:317-33.
  88. Canadian Standards Association. Selection, use, and care of respirators. 1993 (CAN/CSA-Z94.4-93.)
  89. National Institute for Occupational Health and Safety. Guide to industrial respiratory protection. Morgantown, WV: US Department of Health and Human Services, Public Health Service, CDC, 1987; DHHS publication no. (NIOSH) 87-116.
  90. Iseman, MD. A leap of faith: what can we do to curtail intrainstitutional transmission of tuberculosis? Ann Intern Med 1992;117:251-53.
  91. CDC. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system — New York, 1991. MMWR 1992;41:507-09.
  92. CDC. Probable transmission of multidrug-resistant tuberculosis in a correctional facility—California. MMWR 1993;42:48-51.
  93. Pelletier AR, DiFernando GT, Greenberg AJ et al. Tuberculosis in a correctional facility. Arch Intern Med 1993;153:2692-95.
  94. Snider DE. Decision analysis for isoniazid preventive therapy: take it or leave it? Am Rev Respir Dis 1988;137:2-3.
  95. Kopanoff DE, Snider DE,, Caras GJ. Isoniazid-related hepatitis. Am Rev Respir Dis 1978;117:991.
  96. O'Brien RJ. The treatment of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehesive international approach. Vol 66 of Lung biology in health and disease series. Marcel Dekker, New York, 1993:207-40.

[Previous] [Table of Contents]
Last Updated: 1996-09-24 Top
Important Notices